1. Home
  2. TOVX vs SPGC Comparison

TOVX vs SPGC Comparison

Compare TOVX & SPGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TOVX
  • SPGC
  • Stock Information
  • Founded
  • TOVX 2001
  • SPGC 2018
  • Country
  • TOVX United States
  • SPGC United States
  • Employees
  • TOVX N/A
  • SPGC N/A
  • Industry
  • TOVX Biotechnology: Pharmaceutical Preparations
  • SPGC
  • Sector
  • TOVX Health Care
  • SPGC
  • Exchange
  • TOVX Nasdaq
  • SPGC Nasdaq
  • Market Cap
  • TOVX 3.1M
  • SPGC 3.6M
  • IPO Year
  • TOVX 2006
  • SPGC 2023
  • Fundamental
  • Price
  • TOVX $1.37
  • SPGC $1.66
  • Analyst Decision
  • TOVX Strong Buy
  • SPGC
  • Analyst Count
  • TOVX 1
  • SPGC 0
  • Target Price
  • TOVX $6.00
  • SPGC N/A
  • AVG Volume (30 Days)
  • TOVX 4.8M
  • SPGC 102.7K
  • Earning Date
  • TOVX 11-12-2024
  • SPGC 11-14-2024
  • Dividend Yield
  • TOVX N/A
  • SPGC N/A
  • EPS Growth
  • TOVX N/A
  • SPGC N/A
  • EPS
  • TOVX N/A
  • SPGC N/A
  • Revenue
  • TOVX N/A
  • SPGC $2,491,000.00
  • Revenue This Year
  • TOVX N/A
  • SPGC $771.92
  • Revenue Next Year
  • TOVX N/A
  • SPGC $76.31
  • P/E Ratio
  • TOVX N/A
  • SPGC N/A
  • Revenue Growth
  • TOVX N/A
  • SPGC 840.00
  • 52 Week Low
  • TOVX $1.24
  • SPGC $1.52
  • 52 Week High
  • TOVX $17.00
  • SPGC $9.17
  • Technical
  • Relative Strength Index (RSI)
  • TOVX 37.71
  • SPGC 34.00
  • Support Level
  • TOVX $1.31
  • SPGC $1.61
  • Resistance Level
  • TOVX $2.22
  • SPGC $2.07
  • Average True Range (ATR)
  • TOVX 0.24
  • SPGC 0.16
  • MACD
  • TOVX -0.00
  • SPGC 0.03
  • Stochastic Oscillator
  • TOVX 4.51
  • SPGC 10.98

About TOVX Theriva Biologics Inc.

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

About SPGC Sacks Parente Golf Inc.

Sacks Parente Golf Inc is a technology-forward golf company, with a growing portfolio of golf products, including putting instruments, golf shafts, golf grips, and other golf-related products. It designs, manufactures, and sells technology-forward, golf equipment, which is comprised of putting instruments, golf shafts, golf grips, and related product groups. It designs its golf products to fit golfers of all skill levels, amateur and professional. Its business segments currently include, golf putting instruments, golf shafts, and golf related products.

Share on Social Networks: